{
  "id": 356,
  "text": "The 5-year cumulative risk of $\\mathrm { C I N } 2 +$ was $1 .0 \\%$ ( $9 5 \\%$ CI 0.2-4.6) and CIN3 was $0 \\%$ ( $9 5 \\%$ CI 0- 2.9) following a negative co-test at 6 and 24 months (69).Another study found that the 5-year $\\mathrm { C I N } 3 +$ risk after treatment for CIN2/3 for 1, 2 and 3 negative HPV testing or co-testing were $2 .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: The 5-year cumulative risk of $\\mathrm { C I N } 2 +$ was $1 .0 \\%$ ( $9 5 \\%$ CI 0.2-4.6) and CIN3 was $0 \\%$ ( $9 5 \\%$ CI 0- 2.9) following a negative co-test at 6 and 24 months (69).Another study found that the 5-year $\\mathrm { C I N } 3 +$ risk after treatment for CIN2/3 for 1, 2 and 3 negative HPV testing or co-testing were $2 .\n\n<question>: ",
  "ChatGPT_response_0": "在进行阴性共检测后，CIN2+的5年累计风险大约为1.0% （95% CI 0.2-4.6）。 值得注意的是，CIN3的5年累计风险是0%（95% CI 0-2.9）。这表明在接受共检测后，CIN2+的风险相对较低。另外一项研究发现，对于接受CIN2/3治疗的患者，进行1、2和3次阴性HPV检测或共检测后，5年的CIN3 +风险为2%。 综合来看，积极的筛查和监测对于预防和管理宫颈病变非常关键。如果您有任何进一步的疑问或需要更多信息，请随时向您的医疗保健专家咨询。",
  "query": "在进行阴性共检测后，CIN2+的5年累计风险是多少？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在进行阴性共检测后，CIN2+的5年累计风险是多少？\n\n<reference text>: The 5-year cumulative risk of $\\mathrm { C I N } 2 +$ was $1 .0 \\%$ ( $9 5 \\%$ CI 0.2-4.6) and CIN3 was $0 \\%$ ( $9 5 \\%$ CI 0- 2.9) following a negative co-test at 6 and 24 months (69).Another study found that the 5-year $\\mathrm { C I N } 3 +$ risk after treatment for CIN2/3 for 1, 2 and 3 negative HPV testing or co-testing were $2 .\n\n<reply>: ",
  "response": "在进行阴性共检测后，CIN2+的5年累计风险大约为1.0% （95% CI 0.2-4.6）。 值得注意的是，CIN3的5年累计风险是0%（95% CI 0-2.9）。这表明在接受共检测后，CIN2+的风险相对较低。另外一项研究发现，对于接受CIN2/3治疗的患者，进行1、2和3次阴性HPV检测或共检测后，5年的CIN3 +风险为2%。 综合来看，积极的筛查和监测对于预防和管理宫颈病变非常关键。如果您有任何进一步的疑问或需要更多信息，请随时向您的医疗保健专家咨询。"
}